Show simple item record

Comparison of risedronate versus placebo in preventing anastrozole-induced bone loss in women at high risk of developing breast cancer with osteopenia

dc.contributor.authorSestak, Ien_US
dc.contributor.authorBlake, GMen_US
dc.contributor.authorPatel, Ren_US
dc.contributor.authorColeman, REen_US
dc.contributor.authorCuzick, Jen_US
dc.contributor.authorEastell, Ren_US
dc.date.accessioned2019-05-21T10:14:12Z
dc.date.available2019-04-24en_US
dc.date.issued2019-07en_US
dc.identifier.issn8756-3282en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/57661
dc.description.sponsorshipCancer Research UK (C569-A16891)en_US
dc.description.sponsorshipSanofi-Aventis (France)en_US
dc.description.sponsorshipAstraZenecaen_US
dc.format.extent83 - 88en_US
dc.language.isoenen_US
dc.relation.ispartofBONEen_US
dc.subjectOsteopeniaen_US
dc.subjectBone mineral densityen_US
dc.subjectAnastrozoleen_US
dc.subjectRisedronateen_US
dc.subjectBone markeren_US
dc.subjectBreast cancer risken_US
dc.titleComparison of risedronate versus placebo in preventing anastrozole-induced bone loss in women at high risk of developing breast cancer with osteopeniaen_US
dc.typeArticle
dc.rights.holder© 2019 The Authors.
dc.identifier.doi10.1016/j.bone.2019.04.016en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000470340000012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume124en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

Thumbnail
Name:
Sestak_Comparison of risedronate ...
Size:
2.392Mb
Format:
application/
Description:
Accepted version
View/Open

This item appears in the following Collection(s)

Show simple item record